Depot medroxyprogesterone acetate (DMPA) can prevent pregnancy for up to three months, and is available in a form that can be ...

Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who ...

Eli Lilly won approval for its tirzepatide under the names Mounjaro for type 2 diabetes and Zepbound for weight loss -- in ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

A key to the pill's success will be attracting cash-paying consumers who cannot obtain insurance coverage, a stark shift from ...

Currently, the way medicines like insulin and GLP-1s (Wegovy, Ozempic) enter the bloodstream is through subcutaneous injections. Users have to inject themselves, sometimes daily. However, new research ...

Injectable weight loss drugs such as semaglutide and tirzepatide have attracted huge attention, but new real-world data suggest they deliver far less weight loss than surgery outside clinical trials.

Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments ...

People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...